Interim analysis of the clinical performance of five SARS-Cov-2 serology assays

Affiliations

¹ Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada. Electronic address: michael.knauer@lhsc.on.ca.
² Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada.

Michael J Knauer et al. Clin Biochem. 2020 Dec.

. 2020 Dec:86:28-30.

doi: 10.1016/j.clinbiochem.2020.09.002. Epub 2020 Sep 6.

¹ Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada. Electronic address: michael.knauer@lhsc.on.ca.
² Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada.

No abstract available

References

1. W.H. Organization, Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019-nCoV in humans: World Health Organization; 2020.
1. G. Jiang, X. Ren, Y. Liu, H. Chen, W. Liu, Z. Guo, Y. Zhang, C. Chen, J. Zhou, Q. Xiao, H. Shan, Application and optimization of RT-PCR in diagnosis of SARS-CoV-2 infection. medRxiv 2020:2020.02.25.20027755.
1. Petherick A. Developing antibody tests for SARS-CoV-2. Lancet. 2020;395:1101–1102. - PMC - PubMed
1. F. Hoffmann-La Roche Ltd. 2020.
1. DiaSorin 2020.